News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Napo Pharmaceuticals, Inc. Files for MUMS Designation for Crofelemer for Chemotherapy Induced Diarrhea in Dogs


9/13/2012 10:25:52 AM

SAN FRANCISCO--(BUSINESS WIRE)--Napo Pharmaceuticals, Inc. (“Napo”) announced it had applied for a Minor Use in a Major Species (“MUMS”) designation for crofelemer, for use in chemotherapy induced diarrhea in dogs – (“CID”). Crofelemer is also the subject of a pending New Drug Application (“NDA”) for use in humans for the indication of chronic diarrhea in people living with HIV/AIDS.

Read at BioSpace.com

comments powered by Disqus
   
Diarrhea
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES